Publikasjoner - Rasjonell farmakoterapi
Avdeling for klinisk farmakologi
• Langaas HC, Hurley E, Dyrkorn R, Spigset O. Effectiveness of an academic detailing intervention in primary care on the prescribing og non-steriodal anti-inflammatory drugs. Eur J Clin Pharmacol 2019; 75: 577-86.
https://www.ncbi.nlm.nih.gov/pubmed/?term=30596208
• Lien K, Spigset O, Westin A, Slørdal L. Overgangen fra digitoksin til digoksin i årene 2011-13. Tidsskr Nor Legeforen 2018; 133: 1433-8.
https://tidsskriftet.no/2018/10/originalartikkel/overgangen-fra-digitoksin-til-digoksin-i-arene-2011-13
• Mauseth SA, Skurtveit S, Langhammer A, Spigset O. Incidence of and factors associated with anticholinergic drug use among women with urinary incontinence: Data from the Norwegian prescription database and the HUNT study. Int Urogyn J 2918; 89: 489-495.
https://www.ncbi.nlm.nih.gov/pubmed/29103164
• Heltne M, Saltvedt I, Prestmo A, Sletvold O, Spigset O. Patterns of drug prescriptions in an orthogeriatric ward as compared to an orthopaedic ward: Results from The Trondheim Hip Fracture Trial – a randomized clinical trial. Eur J Clin Pharmacol 2017; 73: 937-47.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28550459
• Gjerden P, Bramness JG, Tvete IF, Slørdal L. The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015. Eur J Clin Pharmacol 2017; 73: 1173-9.
https://www.ncbi.nlm.nih.gov/pubmed/?term=28623386
• Brodtkorb E, Samsonsen C, Sund JK, Bråthen G, Helde G, Reimers A. Treatment non-adherence in pseudo-refractory epilepsy. Epilepsy Res 2016; 122: 1-6.
https://www.ncbi.nlm.nih.gov/pubmed/26897547